46 results on '"García-Barberán, Vanesa"'
Search Results
2. In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer
3. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
4. Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors
5. A Snapshot of the Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy
6. Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck
7. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families
8. Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing
9. Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
10. Case report: Clinical success targeting BRAF-mutated, hormone receptor positive, HER2- negative advanced breast cancer patient with BRAF-inhibitor plus MEK- inhibitor
11. Genomic mapping of copy number variations influencing immune response in breast cancer
12. Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1
13. Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas
14. Abstract P3-05-06: Genome-wide DNA methylation analysis identifies novel biomarkers associated with risk of relapse beyond oncotype DX recurrence-score risk assessment within HR+/HER2- early-stage breast cancer patients
15. Abstract P2-01-18: Orthogonal assessment of PIK3CA and ESR1 mutation detection in longitudinal cfDNA samples from endocrine-resistant HR+/HER2- advanced breast cancer patients using dPCR and NGS-based SafeSEQ technology
16. Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma
17. Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
18. Case report: Clinical success targeting BRAF-mutated, hormone receptor positive, HER2- negative advanced breast cancer patient with BRAFinhibitor plus MEK- inhibitor.
19. Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer
20. Additional file 1 of Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
21. Additional file 7 of Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
22. Additional file 8 of Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
23. Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer
24. Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer
25. Comparison of circulating tumor cells and cell-free DNA in the molecular characterization of patients with head and neck cancer.
26. Monitoring of PIK3CA and ESR1 mutations in circulating tumor DNA as predictive and prognostic biomarkers in patients with endocrine-resistant ER+/HER2- advanced breast cancer.
27. Plasma PD-L1 levels according to histologic grade and IDH status in patients with gliomas.
28. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
29. A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
30. A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy
31. Additional file 11: of Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer
32. RAS analysis of circulating tumor cells from advanced colorectal cancer using BEAMing technology.
33. Mutational profile of dysplastic lesions evolving to laryngeal cancer.
34. Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report
35. Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer
36. Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy
37. Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer
38. Evaluation of the sensitivity of RAS mutation detection of the Idylla platform in comparison to the OncoBEAM RAS CRC assay.
39. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome
40. Noninvasive EGFR testing in plasma circulating free DNA (cfDNA) by a new diagnostic method to detect point mutations, deletions and insertions associated to non small cell lung cancer: CLART CMA EGFR LB.
41. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer
42. Incidence of non-canonical IDH mutations and IDH co-mutations in a multicenter prospective study of patients with glioma.
43. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
44. Genomic mapping of copy number variations influencing immune response in breast cancer
45. Estudio y caracterización de las diferencias entre los exosomas aislados en el lavado broncoalveolar y plasma de paciente con cáncer de pulmón avanzado y pacientes con patología no tumoral
46. Capacidad tumorigénica de los ARNms liberados en exosomas en el entorno biológico del cáncer de mama
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.